Inhibition of Leukotriene (SRS‐A)‐Mediated Acute Lung Anaphylaxis by Azelastine in Guinea Pigs
Inhibition of Leukotriene (SRS‐A)‐Mediated Acute Lung Anaphylaxis by Azelastine in Guinea Pigs
复制标题
氮卓斯汀对豚鼠白三烯 (SRS-A) 介导的急性肺部过敏反应的抑制作用
DOI:
--
复制
发表时间:
1986
期刊:
影响因子:
--
通讯作者:
R. Sofia
中科院分区:
文献类型:
--
作者:
N. Chand;K. Nolan;W. Diamantis;J. Perhach;R. Sofia
Azelastine hydrochloride, chemically known as l(2H)‐phthalazinone, 4‐[(4‐chlorophenyl)methyl] ‐2‐(hexahydro‐l‐methyl‐lH‐azepine‐4‐yl)‐, monohydrochloride, is a novel, orally effective, long‐acting, antiallergic/antiasthmatic agent. The ability of azelastine and selected antiallergic drugs to inhibit SRS‐A (leukotriene)‐mediated acute lung anaphylaxis in guinea pigs (Konzett‐Rossler method) was investigated. Azelastine and ketotifen were administered p.o. 2 and 24 h before antigen challenge; disodium cromoglycate (DSCG) was administered i.v. immediately before antigen challenge. The oral dose of azelastine required to inhibit leukotriene‐mediated allergic bronchospasm by 50% (ID50: mg/kg) was 0.063 at 2 h and 0.120 at 24 h. Ketotifen at a dose of 0.05 to 10 mg/kg at 2 and 24 h, p.o., as well as DSCG at a dosage of 0.3 to 10 mg/kg at 0 min, i.v., produced weak, inconsistent and nondose‐related antianaphylactic effects. Azelastine is an orally effective and long‐acting inhibitor of in vivo synthesis and/or release of leukotrienes.